Pharmaceutical Sources

Latest News for: Pharmaceutical sources

Regenacy Pharmaceuticals Announces Patent Issuance for Ricolinostat to Treat Diabetic Peripheral Neuropathy

Herald-Standard 16 Aug 2018

WALTHAM, Mass.--(BUSINESS WIRE)--Aug 16, 2018--Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced the issuance of U.S ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180816005021/en/ ... Regenacy Pharmaceuticals, LLC ... HEALTH BIOTECHNOLOGY PHARMACEUTICAL DIABETES. SOURCE....

Edit

Scientist.com Named One of America’s Ten Fastest-Growing Private Companies by Inc. Magazine

Odessa American 16 Aug 2018

The pharmaceutical industry spends about $150B a year on medical research and produces about 25 new medicines in an average year ... “We are thrilled that Scientist.com is being widely adopted across the pharmaceutical and biotechnology industries.” ... Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, VWR and the US National Institutes of Health (NIH) ... SOURCE....

Edit

2 thyroid medications - Levothyroxine, Liothyronine - recalled over ingredient concerns

ABC7 16 Aug 2018

Westminster Pharmaceuticals, LLC, is recalling Levothyroxine and Liothyronine medications in 15 mg, 30 mg, 60 mg, 90 mg and 120 mg doses....

Edit

Medpace Holdings, Inc. to Present at Baird Global Healthcare Conference

Odessa American 16 Aug 2018

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180815005696/en/ ... SOURCE....

Edit

Appili Therapeutics Announces Results of 2018 Annual and Special Meeting

Olean Times Herald 16 Aug 2018

Bloom, Chair, Chairman & Chief Executive Officer, Bloom Burton & Co.John Holyoake, DPhil, Vice President, Investment Banking, Bloom Burton & Co.Lidija Marusic, PhD, Investment Manager, InnovacorpStephen Nicolle, President, Cape Bear AdvisorsIan Mortimer, President and Chief Financial Officer, Xenon Pharmaceuticals Inc.Kevin Sullivan, MBA, CEO, Appili Therapeutics ... SOURCE....

Edit

BioTime to Present Data at the Military Health System Research Symposium

The Marshall News Messenger 16 Aug 2018

ALAMEDA, Calif.--(BUSINESS WIRE)--Aug 16, 2018--BioTime, Inc. (NYSE American ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180816005061/en/. CONTACT ... KEYWORD ... HEALTH BIOTECHNOLOGY INFECTIOUS DISEASES PHARMACEUTICAL. SOURCE ... .......

Edit

Aeromics, Inc. Appoints Pharmaceutical and Biotech Veterans Mark Day, Ph.D. and Thomas Zindrick, J.D. to ...

Odessa American 16 Aug 2018

BRANFORD, Conn.--(BUSINESS WIRE)--Aug 16, 2018-- (“Aeromics” or “the Company”), a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema, or brain swelling, for people affected by disabling and life-threatening severe ischemic stroke, announced today the appointments of Mark Day, Ph.D ... Their backgrounds within major pharmaceutical companies and biotech will add significant value to our board....

Edit

Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease

Waco Tribune-Herald 16 Aug 2018

MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)--Aug 16, 2018--Sun Pharmaceutical Industries Ltd ... About Sun Pharmaceutical Industries Ltd ... Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company ... In India, the company enjoys leadership across 13 different classes of doctors with 32 brands featuring amongst top 300 pharmaceutical brands in India ... SOURCE....

Edit

Lantheus Holdings to Present at the Wells Fargo Securities 2018 Healthcare Conference

Odessa American 16 Aug 2018

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Aug 15, 2018--Lantheus Holdings, Inc. (the “Company”) (NASDAQ. LNTH), the parent company of Lantheus Medical Imaging, Inc ... Eastern Time ... About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.Lantheus Holdings, Inc ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180815005716/en/. CONTACT ... HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL RADIOLOGY. SOURCE....

Edit

Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Market Watch 16 Aug 2018

Teva Pharmaceutical Industries Ltd. (nyse and tase.TEVA) and Regeneron Pharmaceuticals, Inc ... Teva Pharmaceutical Industries Ltd ... This news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc ... View source version on businesswire.com ... SOURCE. Teva Pharmaceutical Industries Ltd....

Edit

Latin America Conjugate Vaccine Market 2018-2023: A $5.43 Billion Opportunity - ResearchAndMarkets.com

Odessa American 16 Aug 2018

DUBLIN--(BUSINESS WIRE)--Aug 16, 2018--The "Latin America Conjugate Vaccine Market (2018-2023)" report has been added to ResearchAndMarkets.com's offering. The conjugate vaccine market in Latin America is expected to grow at a CAGR of 20.4% leading to revenue of USD 5.43 Bn by 2023 ... Market Segmentation ... Threats ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180816005242/en/ ... HEALTH PHARMACEUTICAL. SOURCE....

Edit

Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Market Watch 16 Aug 2018

Regeneron Pharmaceuticals, Inc ... REGN) and Teva Pharmaceutical Industries Ltd ... Teva Pharmaceutical Industries Ltd ... This news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc ... SOURCE Regeneron Pharmaceuticals, Inc....

Edit

SailPoint Announces Upsizing and Pricing of Follow-On Offering by Selling Stockholders

Market Watch 16 Aug 2018

SailPoint Technologies Holdings, Inc ... The offering was upsized from the previously announced 12,500,000 shares ... Morgan Stanley & Co ... Inc ... LLC, Attention ... 7 of the top 15 banks, 4 of the top 6 healthcare insurance and managed care providers, 9 of the top 15 property and casualty insurance providers, 5 of the top 15 pharmaceutical companies, and 11 of the largest 15 federal agencies. View source version on businesswire.com ... SOURCE ... or....

Edit